Status:

WITHDRAWN

Prospective Investigation of Oxidative Stress in West Nile Virus Infection

Lead Sponsor:

Institute of Tropical Medicine, Belgium

Collaborating Sponsors:

Victor Babes Hospital, Bucharest, Romania

Universiteit Antwerpen

Conditions:

West Nile Virus

West Nile Fever

Eligibility:

All Genders

18+ years

Brief Summary

The investigator hypothesizes that oxidative stress responses to West Nile virus infection in the central nervous system determine the severity of infection and the long-term neurological, neuropsycho...

Eligibility Criteria

Inclusion

  • Willing and able to provide written informed consent. If the clinical condition of the patient does not permit giving consent, informed consent will be obtained from the next of kin.
  • Age 18 years or older
  • for active cases: positive anti-WNV IGM antibodies in serum (or IgG in CSF if applicable)
  • for active cases: presentation within (maximum) 7days of symptom onset
  • for healthy controls: anti-WNV antibody naive (IgM and IgG in serum). The group of healthy controls will be selected to have an age similar distribution to the cases.

Exclusion

  • Evidence of active systemic infection in 3 months prior to recruitment
  • Evidence of systemic inflammatory illness
  • Clinical signs of neurodegenerative or neurologic disease other than WNND
  • Pregnancy
  • Active malignancy
  • History of drug abuse

Key Trial Info

Start Date :

September 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04371003

Start Date

September 1 2020

End Date

December 31 2023

Last Update

February 10 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Victor Babes Hospital

Bucharest, Romania